Leading genomics firm BGI Genomics and global diagnostics company Roche Diagnostics have announced the rollout of new diagnostic tests for Alzheimer’s disease across key regions in China, marking a significant step toward broader and less invasive detection options for one of the world’s most challenging
ICMR validates indigenous innovations that drastically cut testing time and cost, accelerating India’s goal to eliminate tuberculosis by 2025In a major leap toward India’s mission to eliminate tuberculosis (TB), the Indian Council of Medical Research (ICMR) has validated two new Made-in-India diagnostic tests developed by
Chief Guest Dr. Keshav Chandra, Chairman NDMC provides support and inspiration for building a healthier society Camp held at NDMC Head Office to promote early detection of rising lifestyle diseases like diabetes and hypertension Organized by Illness to Wellness Foundation and YoloHealth, free health screening part of larger public health
A team led by Nitin Singhal removed the 8 cm long tumor from a sensitive area behind the abdominal cavity by using advanced da Vinci robotic technology. The tumor was in a challenging location, making removal difficult. However, robotic-assisted surgery minimized surgical trauma, reduced
Collaboration to validate next-generation tests for detection of primary and recurrent/metastatic cancer and personalized treatment response prediction. Partnership aims to enhance precision oncology through advanced novel biomarker-driven diagnostics.HealthCare Global Enterprises Limited (HCG), India’s leading provider of cancer care announced a research collaboration with Trucan
CrisprBits, a biotech start-up specializing in CRISPR gene-editing technology, is excited to announce a strategic collaboration with Molbio Diagnostics, a pioneer in point of care diagnostic solutions. The intent of this collaboration is to revolutionize point of care diagnostics by the introduction of CRISPR in
Partnership will expand use of next-generation sequencing (NGS) to help diagnose patients quickly and more accurately Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) and Trivitron Healthcare, one of India's largest medical technology companies, have entered into a strategic partnership to develop and expand the use of next-generation sequencing
